Intra-Articular Corticosteroid Therapy for Rheumatoid Arthritis Knee Edema

Benefits and Administration

The European League Against Rheumatism recommends intra-articular corticosteroid injections for rapid and effective short-term relief of local symptoms of inflammation in rheumatoid arthritis, with triamcinolone hexacetonide appearing to be the most effective option 1, 2
Intra-articular corticosteroid injections are recommended as an adjunct to disease-modifying antirheumatic drug (DMARD) therapy for patients with one or few residual active joints, with strict aseptic technique being mandatory when performing injections 3, 4
Imaging guidance (e.g., ultrasound) may be used to improve accuracy of injection placement, and prior use of local anesthetic may be desirable, with patients being offered this option with explanation of pros and cons 3

The American College of Rheumatology suggests that for systemic management of RA, low-dose oral prednisone (7.5-10 mg daily) can be effective for controlling symptoms and may slow radiographic progression, with systemic corticosteroids being considered as a mainly temporary adjunct to DMARD therapy 1, 4, 5
For patients on chronic systemic corticosteroids undergoing surgery, continuing the current daily dose is recommended rather than administering "stress dosing", according to the American College of Rheumatology 6, 7

Diabetic patients should be informed about the risk of transient increased glycemia following intra-articular corticosteroid injection, and avoid overuse of injected joints for 24 hours following injection, with complete immobilization being discouraged 3
The decision to reinject a joint should consider benefits from previous injections and other individualized factors, with corticosteroid injections into the same joint being limited to approximately one injection every 6 weeks and no more than 3-4 per year 3